当前位置:首页 - 行情中心 - 莱茵生物(002166) - 财务分析 - 现金流量表

莱茵生物

(002166)

  

流通市值:51.11亿  总市值:51.32亿
流通股本:7.39亿   总股本:7.42亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金1,248,590,624.41799,911,260.951,876,945,197.511,486,182,916.97
  收到的税费返还19,714,395.8919,361,777.9527,124,526.5423,862,794.41
  收到其他与经营活动有关的现金20,031,739.591,679,892.0825,891,029.848,684,811.59
  经营活动现金流入小计1,288,336,759.89820,952,930.981,929,960,753.891,518,730,522.97
  购买商品、接受劳务支付的现金663,233,608.89415,874,342.421,409,249,450.65912,762,861.02
  支付给职工以及为职工支付的现金109,038,279.9361,704,628.4199,540,350.79149,746,011.16
  支付的各项税费44,313,079.7917,914,432.7454,753,223.3441,928,622.31
  支付其他与经营活动有关的现金39,799,332.8312,589,334.21106,209,630.3167,835,326.25
  经营活动现金流出小计856,384,301.44508,082,737.771,769,752,655.091,172,272,820.74
  经营活动产生的现金流量净额431,952,458.45312,870,193.21160,208,098.8346,457,702.23
二、投资活动产生的现金流量:
  收回投资收到的现金246,524.18246,524.181,011,003.25998,683.5
  取得投资收益收到的现金--4,403,059.634,403,059.63
  处置固定资产、无形资产和其他长期资产收回的现金净额54,379.3143,4002,161,880.2136,830.2
  收到的其他与投资活动有关的现金--1,000,000-
  投资活动现金流入小计300,903.49289,924.188,575,943.085,538,573.33
  购建固定资产、无形资产和其他长期资产支付的现金68,739,020.1638,501,822.49162,162,280.89120,246,861.48
  投资活动现金流出小计68,739,020.1638,501,822.49162,162,280.89120,246,861.48
  投资活动产生的现金流量净额-68,438,116.67-38,211,898.31-153,586,337.81-114,708,288.15
三、筹资活动产生的现金流量:
  取得借款收到的现金327,996,544206,000,0001,340,848,408.5789,848,408.5
  收到其他与筹资活动有关的现金--12,600,00012,600,000
  筹资活动现金流入小计327,996,544206,000,0001,353,448,408.5802,448,408.5
  偿还债务支付的现金549,052,884233,648,1971,174,637,456.4789,440,092.5
  分配股利、利润或偿付利息支付的现金94,592,157.3514,246,007.82121,530,331.21103,919,944.56
  支付其他与筹资活动有关的现金240,358.4170,307.549,670,744.7653,188,616.48
  筹资活动现金流出小计643,885,399.75248,064,512.321,345,838,532.37946,548,653.54
  筹资活动产生的现金流量净额-315,888,855.75-42,064,512.327,609,876.13-144,100,245.04
四、汇率变动对现金及现金等价物的影响-2,750,456.68-2,144,401.331,150,099.231,492,697.06
五、现金及现金等价物净增加额44,875,029.35230,449,381.2515,381,736.3589,141,866.1
  加:期初现金及现金等价物余额65,151,142.765,151,142.749,769,406.3549,769,406.35
  期末现金及现金等价物余额110,026,172.05295,600,523.9565,151,142.7138,911,272.45
补充资料:
  净利润57,665,949.55-152,883,586.27-
  资产减值准备-514,982.78--1,344,480.6-
  固定资产和投资性房地产折旧63,890,457.89-122,721,423.88-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧63,890,457.89-122,721,423.88-
  无形资产摊销2,508,266.11-5,036,987.98-
  长期待摊费用摊销417,828.84-1,095,257.04-
  处置固定资产、无形资产和其他长期资产的损失--129,684.76-
  固定资产报废损失180,506.29-3,361,840.68-
  公允价值变动损失-3,678,915.73--4,246,764.89-
  财务费用19,802,561.57-42,887,561.83-
  投资损失-2,246,739.28--4,600,454.64-
  递延所得税460,899.54-4,557,980.05-
  其中:递延所得税资产减少-949,414.45-4,472,040.83-
    递延所得税负债增加1,410,313.99-85,939.22-
  存货的减少223,801,811.26--100,813,264.32-
  经营性应收项目的减少365,145,547.8--258,131,098.79-
  经营性应付项目的增加-295,402,687.16-179,671,166.63-
  其他-1,571,862.95-13,576,369.23-
  现金的期末余额110,026,172.05-65,151,142.7-
  减:现金的期初余额65,151,142.7-49,769,406.35-
  现金及现金等价物的净增加额44,875,029.35-15,381,736.35-
公告日期2026-08-292026-04-302026-03-312025-10-28
审计意见(境内)标准无保留意见
TOP↑